These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8565165)

  • 1. Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension.
    Raffy O; Azarian R; Brenot F; Parent F; Sitbon O; Petitpretz P; Hervé P; Duroux P; Dinh-Xuan AT; Simonneau G
    Circulation; 1996 Feb; 93(3):484-8. PubMed ID: 8565165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilator therapy for primary pulmonary hypertension in children.
    Barst RJ; Maislin G; Fishman AP
    Circulation; 1999 Mar; 99(9):1197-208. PubMed ID: 10069788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A noninvasive assessment of pulmonary perfusion abnormality in patients with primary pulmonary hypertension.
    Ting H; Sun XG; Chuang ML; Lewis DA; Hansen JE; Wasserman K
    Chest; 2001 Mar; 119(3):824-32. PubMed ID: 11243964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
    McLaughlin VV; Genthner DE; Panella MM; Rich S
    N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension.
    Petitpretz P; Brenot F; Azarian R; Parent F; Rain B; Herve P; Simonneau G
    Circulation; 1994 Jun; 89(6):2722-7. PubMed ID: 8205687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
    Nakayama T; Ishikita T; Matsuura H; Saji T
    J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery.
    Schranz D; Zepp F; Iversen S; Wippermann C; Huth R; Zimmer B; Jüngst BK; Oelert H
    Crit Care Med; 1992 Sep; 20(9):1243-9. PubMed ID: 1521438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.
    Sitbon O; Brenot F; Denjean A; Bergeron A; Parent F; Azarian R; Herve P; Raffestin B; Simonneau G
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):384-9. PubMed ID: 7842196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.
    Barst RJ; Rubin LJ; McGoon MD; Caldwell EJ; Long WA; Levy PS
    Ann Intern Med; 1994 Sep; 121(6):409-15. PubMed ID: 8053614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute absolute vasodilatation is associated with a lower vascular wall stiffness in pulmonary arterial hypertension.
    Grignola JC; Domingo E; Aguilar R; Vázquez M; López-Messeguer M; Bravo C; Roman A
    Int J Cardiol; 2013 Apr; 164(2):227-31. PubMed ID: 21788089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension.
    Wax D; Garofano R; Barst RJ
    Chest; 1999 Oct; 116(4):914-20. PubMed ID: 10531153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure.
    Montalescot G; Drobinski G; Meurin P; Maclouf J; Sotirov I; Philippe F; Choussat R; Morin E; Thomas D
    Am J Cardiol; 1998 Sep; 82(6):749-55. PubMed ID: 9761085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous therapy with intravenous prostacyclin for primary pulmonary hypertension: a bridge to heart-lung transplantation.
    Kramer MR; Fucks S; Simon Z; Berkman N
    Isr J Med Sci; 1993 Oct; 29(10):613-6. PubMed ID: 8244657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension.
    Friedman R; Mears JG; Barst RJ
    Circulation; 1997 Nov; 96(9):2782-4. PubMed ID: 9386137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.
    Nagaya N; Uematsu M; Okano Y; Satoh T; Kyotani S; Sakamaki F; Nakanishi N; Miyatake K; Kunieda T
    J Am Coll Cardiol; 1999 Oct; 34(4):1188-92. PubMed ID: 10520811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary and systemic hemodynamic responses to intravenous prostacyclin in broilers.
    Wideman RF; Chapman ME; Erf GF
    Poult Sci; 2005 Mar; 84(3):442-53. PubMed ID: 15782913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
    Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
    J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension.
    Kumar VH; Swartz DD; Rashid N; Lakshminrusimha S; Ma C; Ryan RM; Morin FC
    J Appl Physiol (1985); 2010 Sep; 109(3):677-84. PubMed ID: 20616229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary pulmonary hypertension.
    Gaine SP; Rubin LJ
    Lancet; 1998 Aug; 352(9129):719-25. PubMed ID: 9729004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.